Drugs / Octisalate
last change Feb 2019 re-read 2 minutes ago

Octisalate

Small molecule

Investigated by
Food and Drug Administration (FDA) · Spaulding Clinical Research LLC

Trials 1 · a red edge is where a trial was stopped

20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT03582215 Jul 2018 → Feb 2019 skin sensitivity to sun Food and Drug Administration (FDA) Completed No outcome recorded

Evidence & citations 9 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Octisalate “Ingredients: 3% Avobenzone; 6% Oxybenzone; 2.35% Octocrylene; 15% Homosalate; 5% OctisalateNCT03582215
Known as Escalol ChEMBL registry synonym — accepted as the source's own label CHEMBL1329203
Known as Ethyl hexyl salicylate ChEMBL registry synonym — accepted as the source's own label CHEMBL1329203
Known as Neo heliopan ChEMBL registry synonym — accepted as the source's own label CHEMBL1329203
Known as NSC-46151 ChEMBL registry synonym — accepted as the source's own label CHEMBL1329203
Known as Octisalato ChEMBL registry synonym — accepted as the source's own label CHEMBL1329203
Known as Octyl salicylate ChEMBL registry synonym — accepted as the source's own label CHEMBL1329203
Known as Uvinul ChEMBL registry synonym — accepted as the source's own label CHEMBL1329203
Modality Small molecule CHEMBL1329203